Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frequent high-dose dexamethasone for primary immune thrombocytopenic purpura
IRCT2015110424881N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexamethasone in immune thrombocytopenia (ITP), sponsored by Zahedan University of Medical Sciences. Started Mar 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on IRCT2015110424881N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015110424881N1.